Working… Menu

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02314923
Recruitment Status : Completed
First Posted : December 11, 2014
Last Update Posted : August 22, 2017
BioProtection Systems Corporation
Department of Health and Human Services
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.